Literature DB >> 18463146

High free thyroxine levels are associated with QTc prolongation in males.

Charlotte van Noord1, Wendy M van der Deure, Miriam C J M Sturkenboom, Sabine M J M Straus, Albert Hofman, Theo J Visser, Jan A Kors, Jacqueline C M Witteman, Bruno H Ch Stricker.   

Abstract

The literature on the effect of excess thyroid hormone on ventricular repolarization is controversial. To study whether free thyroxine (T(4)) and TSH are associated with QTc prolongation we conducted population-based cohort study. This study was conducted as part of the Rotterdam Study and included 365 men and 574 women aged 55 years and older with an electrocardiogram, who were randomly sampled for the assessment of thyroid status (free T(4)/TSH) at baseline, after exclusion of participants with hypothyroidism, use of antithyroid drugs, thyroid hormones or digoxin, left ventricular hypertrophy, and left and right bundle branch block. Endpoints were the length of the QTc interval and risk of borderline QTc prolongation. The associations were examined by means of linear and logistic regression analysis, adjusted for age and gender, diabetes mellitus, myocardial infarction, hypertension, and heart failure. Overall, there was no significant association between TSH and QTc interval (0.8 ms (95% confidence interval (CI) -3.5, 5.2) in the first quintile compared with the fifth quintile). Subjects in the fifth quintile of free T(4) did not have an increased QTc interval (3.2 ms (95% CI -1.1, 7.6)); stratification on gender showed an increment of 10.9 ms (95% CI 3.4, 18.3) in the fifth quintile in men and 1.1 ms (95% CI -4.2, 6.3) in the fifth quintile of free T(4) in women. When compared with subjects in the first quintile, male subjects in the fifth quintile of free T(4) had a significantly increased risk of a borderline QTc interval and QTc prolongation (odds ratio 2.40 (95% CI 1.20, 4.80)). High levels of free T(4) are associated with substantial QTc prolongation in men of up to 10 ms. The fact that free T(4) is also associated with a significantly increased risk of borderline and prolonged QTc values with its risk of sudden cardiac death, endorses the clinical importance of our findings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463146     DOI: 10.1677/JOE-08-0140

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

Review 1.  Drug- and non-drug-associated QT interval prolongation.

Authors:  Charlotte van Noord; Mark Eijgelsheim; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

2.  Thyroid-stimulating hormone within the normal range and risk of major adverse cardiovascular events in nonischemic dilated cardiomyopathy patients with severe left ventricular dysfunction.

Authors:  Xiaofei Li; Yan Yao; Zhaoran Chen; Siyang Fan; Wei Hua; Shu Zhang; Xiaohan Fan
Journal:  Clin Cardiol       Date:  2018-12-20       Impact factor: 2.882

3.  QT prolongation in a child with thyroid storm.

Authors:  Benjamin B Albert; Luke Gerard Eckersley; Jonathan Robert Skinner; Craig Jefferies
Journal:  BMJ Case Rep       Date:  2014-04-12

4.  Population-based studies of antithyroid drugs and sudden cardiac death.

Authors:  Charlotte van Noord; Miriam C J M Sturkenboom; Sabine M J M Straus; Albert Hofman; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

5.  Thyroid dysfunction and electrocardiographic changes in subjects without arrhythmias: a cross-sectional study of primary healthcare subjects from Copenhagen.

Authors:  Bhupendar Tayal; Claus Graff; Christian Selmer; Kristian Hay Kragholm; Magnus Kihlstrom; Jonas Bille Nielsen; Anne-Marie Schjerning Olsen; Adrian Holger Pietersen; Anders G Holst; Peter Søgaard; Christine Benn Christiansen; Jens Faber; Gunnar Hilmar Gislason; Christian Torp-Pedersen; Steen M Hansen
Journal:  BMJ Open       Date:  2019-06-21       Impact factor: 2.692

Review 6.  Acquired long QT syndrome in chronic kidney disease patients.

Authors:  Peng Liu; Lu Wang; Dan Han; Chaofeng Sun; Xiaolin Xue; Guoliang Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

7.  Thyroid hormones regulate cardiac repolarization and QT-interval related gene expression in hiPSC cardiomyocytes.

Authors:  Alessandra Ulivieri; Luca Lavra; Fiorenza Magi; Alessandra Morgante; Leonardo Calò; Patrizio Polisca; Leila B Salehi; Salvatore Sciacchitano
Journal:  Sci Rep       Date:  2022-01-12       Impact factor: 4.379

8.  Thyroid hormones and electrocardiographic parameters: findings from the third national health and nutrition examination survey.

Authors:  Yiyi Zhang; Wendy S Post; Alan Cheng; Elena Blasco-Colmenares; Gordon F Tomaselli; Eliseo Guallar
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

Review 9.  Incidence and risk of QTc interval prolongation among cancer patients treated with vandetanib: a systematic review and meta-analysis.

Authors:  Jiajie Zang; Shunquan Wu; Lei Tang; Xudong Xu; Jie Bai; Caicui Ding; Yue Chang; Long Yue; Enming Kang; Jia He
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

10.  The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval.

Authors:  Ye Seung Lee; Joong Wan Choi; Eun Ju Bae; Won Il Park; Hong Jin Lee; Phil Soo Oh
Journal:  Korean J Pediatr       Date:  2015-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.